MedTrace Logo

Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

NCT03906539 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-04-06

No results posted yet for this study

Summary

The present research will help to assess the effect of virgin coconut oil on cholesterol level and also will help to know whether virgin coconut oil can reduce the risk of heart diseases or not.

Conditions

  • Dyslipidemias

Interventions

DRUG

Atorvastatin 10mg

Atorvastatin 10 mg per day

DIETARY_SUPPLEMENT

Virgin Coconut Oil (VCO)

Capsule VCO (1000 mg/day)

OTHER

Placebo

Placebo capsule - 1 capsule per day

Sponsors & Collaborators

  • Coconut Development Board, Government of India

    collaborator UNKNOWN

  • All India Institute of Medical Sciences, Bhubaneswar

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-22
Primary Completion
2021-11-30
Completion
2021-12-31

Countries

  • India

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03906539 on ClinicalTrials.gov